NF2-Related Intravestibular Schwannomas: Long-Term Outcomes of Cochlear Implantation

被引:11
|
作者
Jia, Huan [1 ,4 ]
Nguyen, Yann [1 ,3 ]
Hochet, Baptiste [1 ]
Smail, Mustapha [1 ]
Mosnier, Isabelle [1 ]
Wu, Hao [4 ]
Sterkers, Olivier [1 ,3 ,4 ]
Kalamarides, Michel [2 ,3 ]
Bernardeschi, Daniele [1 ]
机构
[1] GH Pitie Salperriere, AP HP,Rare Dis Ctr Genet Deafiless Adult, Dept Otol Auditory Implants & Skull Base Surg, Ile de France Reference Ctr Cochlear Implant & Au, Paris, France
[2] GH Pitie Salperriere, AP HP, Dept Neurosurg, Rare Dis Ctr NF2, Paris, France
[3] Sorbonne Univ, Paris, France
[4] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Cochlear implant; Intra-labyrinthine tumor; Intravestibular tumor; Neurofibromatosis type 2; Vestibular schwannoma; INTRALABYRINTHINE SCHWANNOMAS; HEARING PRESERVATION; DECOMPRESSION; DIAGNOSIS; REMOVAL; SERIES; MRI;
D O I
10.1097/MAO.0000000000002431
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Intravestibular schwannomas (IVS) are uncommon tumors in Neurofibromatosis type 2 (NF2) and are mainly associated with multiple internal auditory meatus (IAM) and cerebellopontine angle (CPA) tumors. They usually induce profound hearing loss which can be rehabilitated by cochlear implantation (CI). The aim of this study was to analyze the long-term outcomes of CI during the unpredictable evolution of NF2 disease. Study Design: Retrospective case review. Setting: Tertiary referral center. Patients: Three adults with neurofibromatosis type 2 and intravestibular schwannomas, and who were cochlear implant recipients. Interventions: Periodic radiologic follow-up, tumor resection, and hearing rehabilitation. Main Outcome Measures: Audiological evolution, tumor evolution, surgical outcome, cochlear implant outcome. Results: Three NF2 patients (mean age at diagnosis, 26.3 +/- 3.2 yr) were identified with IVS in the period between 2000 and 2017. IVS were first observed by serial MRI and profound hearing loss occurred in this ear after 4 +/- 1.5 years of follow-up. IVS were removed via a translabyrinthine approach, and ipsilateral cochlear implantations were simultaneously performed. In two patients, large contralateral CPA tumors had previously been removed without hearing preservation, whereas in the third patient, a small, growing contralateral VS was excised via a retrosigmoid approach 6 months after IVS removal/cochlear implantation with serviceable hearing preservation. In all cases, CI provided good hearing outcomes. In two cases, hearing outcomes were even better for more than 5 years when ipsilateral intracanalicular vestibular schwannomas were removed in either the same or subsequent procedures. Conclusions: Rehabilitation of hearing with CI provides a favorable long-term outcome in patients with NF2-related IVS which could be altered by the occurrence of other intracanalicular and/or CPA NF2-related tumors.
引用
收藏
页码:94 / 99
页数:6
相关论文
共 50 条
  • [31] IDENTIFICATION AND TARGETING OF TUMOR DRIVER SCHWANN(NF2LOSS) CELLS IN SPORADIC AND NF2-RELATED VESTIBULAR SCHWANNOMAS
    Laws, Maxwell
    Asuzu, David
    Rampalli, Ihika
    Mullaney, Dustin
    Laraba, Liyam
    Mandel, Debjani
    Zhang, Xiyuan
    Elkahloun, Abdel
    Sisay, Bayu
    Maric, Dragan
    Johnson, Kory
    Abdullaev, Zied
    Aldape, Kenneth
    Shern, John
    Parkinson, David
    Chittiboina, Prashant
    NEURO-ONCOLOGY, 2024, 26
  • [32] INTRATUMORAL CONCENTRATION AND MOLECULAR PHARMACODYNAMICS OF LAPATINIB IN VIVO IN SPORADIC AND NF2-RELATED VESTIBULAR SCHWANNOMAS
    Karajannis, Matthias
    Bergner, Amanda
    Giovannini, Marco
    Welling, D. Bradley
    Niparko, John
    Slattery, William
    Roland, J. Thomas
    Golfinos, John
    Allen, Jeffrey
    Blakeley, Jaishri
    NEURO-ONCOLOGY, 2012, 14 : 19 - 19
  • [33] Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis
    Dornhoffer, James R.
    Plitt, Aaron R.
    Lohse, Christine M.
    Driscoll, Colin L. W.
    Neff, Brian A.
    Saoji, Aniket A.
    Van Gompel, Jamie J.
    Link, Michael J.
    Carlson, Matthew L.
    OTOLOGY & NEUROTOLOGY, 2024, 45 (01) : 29 - 35
  • [34] Long-Term Outcomes of Cochlear Implantation in Patients With High-Frequency Hearing Loss
    Roland, J. Thomas, Jr.
    Gantz, Bruce J.
    Waltzman, Susan B.
    Parkinson, Aaron J.
    LARYNGOSCOPE, 2018, 128 (08): : 1939 - 1945
  • [35] Functional Outcomes and Quality of Life after Cochlear Implantation in Patients with Long-Term Deafness
    Ovari, Attila
    Huehnlein, Lisa
    Nguyen-Dalinger, David
    Strueder, Daniel Fabian
    Kuelkens, Christoph
    Niclaus, Oliver
    Meyer, Jens Eduard
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [36] Long-term audiologic outcomes after cochlear implantation for single-sided deafness
    Sullivan, Christopher Blake
    Al-Qurayshi, Zaid
    Zhu, Vivian
    Liu, Andrew
    Dunn, Camille
    Gantz, Bruce J.
    Hansen, Marlan R.
    LARYNGOSCOPE, 2020, 130 (07): : 1805 - 1811
  • [37] Long-Term Evaluation of Cochlear Implantation in Cogan Syndrome
    Kontorinis, Georgios
    Giourgas, Alexandros
    Neuburger, Juergen
    Lesinski-Schiedat, Anke
    Lenarz, Thomas
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2010, 72 (05): : 275 - 279
  • [38] Synergistic effects of combined BET and FAK inhibition against Vestibular Schwannomas in NF2-related Schwannomatosis
    Gonzalez-Rodriguez, Maria A.
    Troutman, Scott
    Bayle, Simon
    Lester, Daniel K.
    Grove, Matthew
    Duckett, Derek
    Kareta, Michael S.
    Kissil, Joseph L.
    ONCOGENE, 2024, 43 (40) : 2995 - 3002
  • [39] Long-term effects of second cochlear implantation with sequential bilateral cochlear implantation in Japanese children
    Mori, Naoe
    Yamamoto, Norio
    Yamaguchi, Shinobu
    Kondo, Kanako
    Yoshizawa, Misaki
    Okano, Takayuki
    Ito, Juichi
    Omori, Koichi
    AURIS NASUS LARYNX, 2024, 51 (01) : 138 - 146
  • [40] Intramedullary schwannomas: long-term outcomes of ten operated cases
    Soo Eon Lee
    Chun Kee Chung
    Hyun-Jib Kim
    Journal of Neuro-Oncology, 2013, 113 : 75 - 81